Psychoactive drug prescribing by Dutch child and adolescent psychiatrists

Acta Paediatrica, International Journal of Paediatrics

Volumn 94, Issue 10, 2005, Pages 1484-1487

  Hugtenburg, Jacqueline G ^a   Heerdink, Eibert R ^a   Tso, Yung Hwo ^b  

^a UTRECHT UNIVERSITY   (Netherlands)

^b Practice for Child and Adolescent Psychiatry   (Netherlands)

Author keywords

Child psychiatrists; Children; Off label use; Prescribing of psychoactive drugs; Questionnaire

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; FLUOXETINE; FLUVOXAMINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; OXAZEPAM; PAROXETINE; PIMOZIDE; PIPAMPERONE; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; RISPERIDONE; SERTRALINE; TEMAZEPAM;

ARTICLE; CHILD; CHILD PSYCHIATRY; DRUG PREFERENCE; HUMAN; MAJOR CLINICAL STUDY; MENTAL DISEASE; NETHERLANDS; PRESCRIPTION; PRIORITY JOURNAL; PSYCHIATRIST; QUESTIONNAIRE;

ADOLESCENT; ADOLESCENT PSYCHIATRY; CHILD; CHILD PSYCHIATRY; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DRUG UTILIZATION; FEMALE; HUMANS; INCIDENCE; MALE; MENTAL DISORDERS; NETHERLANDS; PHYSICIAN'S PRACTICE PATTERNS; PSYCHOTROPIC DRUGS; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 27144476807     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1080/08035250510036840     Document Type: Article

References (16)

1. Safer DJ, Zito JM, Fine EM. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 1996;98:1084-8.
2. Zwi M, Ramchandani P, Joughin C. Evidence and belief in ADHD. Br Med J 2000;321:975-6.
3. Schirm E, Tobi H, Zito JM, De Jong-van den Berg LT. Psychotropic medication in children: A study from the Netherlands. Pediatrics 2001;108:e25.
4. Efron D, Hiscock H, Sewell JR, Cranswick WE, Vance AL, Tyl Y, et al. Prescribing of psychotropic medications for children by Australian pediatricians and child psychiatrists. Pediatrics 2003;11:372-5.
5. Masi G, Cosenza A, Mucci M, De Vito G. Risperidone monotherapy in preschool children with pervasive developmental disorders. J Child Neurol 2001;16:395-400.
6. Vercellino F, Zanotto E, Ravera G, Veneselli E. Open-label risperidone treatment of 6 children and adolescents with autism. Can J Psychiatry 2001;46:559-60.
7. Sikich L, Hamer RM, Bashford RA, Sheitman BB, Lieberman JA. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: A double-blind, randomized, 8-week trial. Neuropsychopharmacol 2003; DOI: 10.1038/sj.npp. 1300327.
8. McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, et al. Risperidone in children with autism and serious behavioural problems. New Engl J Med 2002;347:314-21.
9. Bruggeman R, Van der Linden C, Buitelaar JK, Gericke GS, Hawkridge SM, Temlett JA. Risperidone versus pimozide in Tourette's disorder: a comparative double-blind parallel-group study. J Clin Psychiatry 2001;62:50-6.
10. Dion Y, Annable L, Sandor P, Chouinard G. Risperidone in the treatment of Tourette syndrome: a double-blind, placebo-controlled trial. J Clin Psychopharmacol 2002;22:31-9.
11. Scahill L, Leckman JF, Schultz RT, Katsovich L, Pederson BS. A placebo-controlled trial of risperidone in Tourette syndrome. Neurology 2003;60:1130-5.
12. Glazener CM, Evans JH, Peto RE. Tricyclic and related drugs for nocturnal enuresis in children. Cochrane Database Syst Rev 2003;(3):CD002117.
13. Pathiyal A, Hylan TR, Jones JK, Davtian D, Sverdlov L, Keyser M. Prescribing of selective serotonin reuptake inhibitors, anxiolytics, and sedative-hypnotics by general practitioners in The Netherlands: a multivariate analysis. Clin Ther 1997;19:798-810.
14. Kim SS. Role of fluoxetine in anorexia nervosa. Ann Pharmacother 2003;37:890-2.
15. Bramble D. Annotation: The use of psychotropic medications in children: a British view. J Child Psychol Psychiatry 2003;44:169-79.
16. Clark AF. Incidences of new prescribing by British child and adolescent psychiatrists: a prospective study over 12 months. J Psychopharmacol 2004;18:115-20.